Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

NCT00102414 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

356

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Gemcitabine

Sponsor

AGO Study Group